• Info
  • Insider Trading

Samuel Kintz - Insider Trading & Ownership

Location
Enliven Therapeutics Inc, 6200 Lookout Road, Boulder, CO
Summary
The estimated net worth of Samuel Kintz is at least $19.4M dollars as of November 19, 2025. Samuel Kintz is the PRESIDENT AND CEO, Director of Enliven Therapeutics, Inc. and owns shares of Enliven Therapeutics, Inc. (ELVN) stock worth about $19.4M.
Signature
/s/ Ben Hohl, by power of attorney
All Insider Reports
All Insider Reports

Notify me when Samuel Kintz files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of Samuel Kintz

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
ELVN, IMRA Enliven Therapeutics, Inc. PRESIDENT AND CEO, Director $19.4M -$2.1M -9.76% Nov 17, 2025

Insider Transactions Reported by Samuel Kintz:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.